The current status of bladder preservation in the treatment of muscle invasive bladder cancer

Journal of Urology

Volumn 164, Issue 3 I, 2000, Pages 627-632

  Kim, Hyung L ^a   Steinberg, Gary D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bladder; Bladder neoplasms; Bladder preservation; Cystectomy; Neoplasm invasiveness

Indexed keywords

CISPLATIN; FLUOROURACIL; METHOTREXATE; RADIOSENSITIZING AGENT;

BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 0033875510     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-200009010-00002     Document Type: Review

References (53)

1. Barnes, R. W., Dick, A. L., Hadley, H. L. et al: Survival following transurethral resection of bladder carcinoma. Cancer Res, 37: 2895, 1977
2. Herr, H. W.: Conservative management of muscle-infiltrating bladder tumors: prospective experience. J Urol, 138: 1162, 1987
3. Roberts, J. T., Fossa, S. D., Richards, B. et al: Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder. Br J Urol, 68: 162, 1991
4. Duncan, W. and Quilty, P. M.: The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol, 7: 299, 1986
5. Gospodarowicz, M. K., Hawkins, N. V., Rawlings, G. A. et al: Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol, 142:1448,1989
6. Pollack, A., Zagars, G. K and Swanson, D. A.: Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys, 30: 267, 1994
7. Klan, R., Loy, V. and Huland, H.: Residual tumor discovered in routine second TUR in patients with stage T1 transitional cell carcinoma of the bladder. J Urol, 146: 316, 1991
8. Herr, H. W.: The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol, 162:74, 1999
9. Miller, L. S.: Bladder cancer: superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer, suppl., 39: 973, 1977
10. Bloom, H. J., Hendry, W. F., Wallace, D. M. et al: Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol, 54:136, 1982
11. Sell, A., Jakobsen, A., Nerstrom, B. et al: Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group. Scand J Urol Nephrol, suppl., 138: 193, 1991
12. Skinner, D. G. and Lieskovsky, G.: Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol, 131:1069, 1984
13. Jenkins, B. J., Caulfield, M. J., Fowler, C. G. et al: Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol, 62: 343, 1988
14. Mameghan, H., Fisher, R., Mameghan, J. et al: Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys, 31: 247, 1995
15. Quilty, P. M. and Duncan, W.: Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys, 12: 853, 1986
16. Skinner, D. G., Daniels, J. R., Russell, C. A. et al: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol, 145: 459, 1991
17. Horoit, J. C., Le Fur, R., N'Guyen, T. et al: Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol, 25: 231, 1992
18. Herskovic, A., Martz, K., al-Sarraf, M. et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med, 326: 1593, 1992
19. Housset, M., Maulard, C., Chretien, Y. et al: Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol, 11: 2150, 1993
20. Zietman, A. L., Shipley, W. U., Kaufman, D. S. et al: A phase I/II trial of transurethral surgery combined with concurrent cis-platin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer. J Urol, 160: 1673, 1998
21. Naslund, I., Nilsson, B. and Littbrand, B.: Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial. Acta Oncol, 33: 397, 1994
22. Sauer, R., Birkenhake, S., Kuhn, R. et al: Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys, 40: 121, 1998
23. Fellin, G., Graffer, U., Bolner, A. et al: Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study. Br J Urol, 80: 44, 1997
24. Tester, W., Porter, A., Asbell, S. et al: Combined modality program with possible organ preservation for invasive bladder cancer: results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys, 25: 783, 1993
25. Shipley, W. U., Kaufman, D. S., Heney, N. M. et al: An update of selective bladder preservation by combined modality therapy for invasive bladder cancer. Eur Urol, suppl., 33: 32, 1998
26. Tester, W., Caplan, R., Heaney, J. et al: Neoadjuvant combined modality program with selective organ preservation for inva-sive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol, 14: 119, 1996
27. Shipley, W. U., Winter, K A., Kaufman, D. S. et al: Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol, 16: 3576, 1998
28. Kachnic, L. A., Kaufman, D. S., Heney, N. M. et al: Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol, 15: 1022, 1997
29. Frazier, H. A., Robertson, J. E., Dodge, R. K. et al: The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer, 71:3993, 1993
30. Montie, J. E., Straffon, R. A. and Stewart, B. H.: Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol, 131: 477, 1984
31. Pagano, F., Bassi, P., Galetti, T. P. et al: Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol, 145: 45, 1991
32. Brendler, C. B., Steinberg, G. D., Marshall, F. F. et al: Local recurrence and survival following nerve-sparing radical cystoprostatectomy. J Urol, 144: 1137, 1990
33. Given, R. W., Parsons, J. T., McCarley, D. et al: Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up. Urology, 46: 499, 1995
34. Hautmann, R. E.: Complications and results after cystectomy in male and female patients with locally invasive bladder cancer. Eur Urol, suppl., 33: 23, 1998
35. Abratt, R. P., Wilson, J. A., Pontin, A. R. et al: Salvage cystectomy after radical irradiation for bladder cancer: prognostic factors and complications. Br J Urol, 72: 756, 1993
36. Schultz, P. K, Herr, H. W., Zhang, Z. F. et al: Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. J Clin Oncol, 12: 1394, 1994
37. Stein, J. P., Grossfeld, G. D., Ginsberg, D. A. et al: Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol, 160: 645, 1998
38. Lerner, S. P.: Editorial comment. J Urol, 160: 645, 1998
39. Stenzl, A., Colleselli, K., Poisel, S. et al: Rationale and technique of nerve sparing radical cystectomy before an orthotopic neobladder procedure in women. J Urol, 154: 2044, 1995
40. Cancrini, A., De Carli, P., Pompeo, V. et al: Lower urinary tract reconstruction following cystectomy: experience and results in 96 patients using the orthotopic ileal bladder substitution of Studer et al. Eur Urol, 29: 204, 1996
41. Kolettis, P. N., Klein, E. A., Novick, A. C. et al: The Le Bag orthotopic urinary diversion. J Urol, 156: 926, 1996
42. Christiano, A. P., Hollowell, C. M. P. and Steinberg, G. D.: Impact of Hautmann neobladder chimney modification on ureteral stenosis. J Urol, suppl., 161: 67, abstract 252, 1999
43. Hautmann, R. E., de Petriconi, R., Gottfried, H.-W. et al: The ileal neobladder: complications and functional results in 363 patients after 11 years of followup. J Urol, 161: 422, 1999
44. Hart, S., Skinner, E. C., Meyerowitz, B. E. et al: Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, or cutaneous or urethral kock pouch. J Urol, 162: 77, 1999
45. Cox, J. D., Guse, C., Asbell, S. et al: Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys, 15:1331, 1988
46. Lynch, W. J., Jenkins, B. J., Fowler, C. G. et al: The quality of life after radical radiotherapy for bladder cancer. Br J Urol, 70: 519, 1992
47. Skinner, D. G., Stein, J. P., Lieskovsky, G. et al: 25-year experience in the management of invasive bladder cancer by radical cystectomy. Eur Urol, suppl., 33: 25, 1998
48. Waehre, H., Ous, S., Klevmark, B. et al: A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer. Cancer, 72: 3044, 1993
49. Malmström, P.-U., Rintala, E., Wahlqvist, R. et al: Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. J Urol, 155: 1903, 1996
50. Lytton, B.: Editorial comment. N Engl J Med, 330: 867, 1994
51. Einstein, A. B., Jr., Wolf, M., Halliday, K. R. et al: Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study. Urology, 47: 652, 1996
52. Schoenberg, M. P., Walsh, P. C., Breazeale, D. R. et al: Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol, 155: 490, 1996
53. Scher, H. I., Yagoda, A., Herr, H. W. et al: Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion. J Urol, 139: 470, 1988